Literature DB >> 24379358

Induction of amphiregulin by p53 promotes apoptosis via control of microRNA biogenesis in response to DNA damage.

Naoe Taira1, Tomoko Yamaguchi, Junko Kimura, Zheng-Guang Lu, Shinji Fukuda, Shigeki Higashiyama, Masaya Ono, Kiyotsugu Yoshida.   

Abstract

Upon DNA damage, tumor suppressor p53 determines cell fate by repairing DNA lesions to survive or by inducing apoptosis to eliminate damaged cells. The decision is based on its posttranslational modifications. Especially, p53 phosphorylation at Ser46 exerts apoptotic cell death. However, little is known about the precise mechanism of p53 phosphorylation on the induction of apoptosis. Here, we show that amphiregulin (AREG) is identified for a direct target of Ser46 phosphorylation via the comprehensive expression analyses. Ser46-phosphorylated p53 selectively binds to the promoter region of AREG gene, indicating that the p53 modification changes target genes by altering its binding affinity to the promoter. Although AREG belongs to a family of the epidermal growth factor, it also emerges in the nucleus under DNA damage. To clarify nuclear function of AREG, we analyze AREG-binding proteins by mass spectrometry. AREG interacts with DEAD-box RNA helicase p68 (DDX5). Intriguingly, AREG regulates precursor microRNA processing (i.e., miR-15a) with DDX5 to reduce the expression of antiapoptotic protein Bcl-2. These findings collectively support a mechanism in which the induction of AREG by Ser46-phosphorylated p53 is required for the microRNA biogenesis in the apoptotic response to DNA damage.

Entities:  

Keywords:  Drosha; miRNA processing; microarray

Mesh:

Substances:

Year:  2013        PMID: 24379358      PMCID: PMC3896180          DOI: 10.1073/pnas.1313675111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Label-free quantitative proteomics using large peptide data sets generated by nanoflow liquid chromatography and mass spectrometry.

Authors:  Masaya Ono; Miki Shitashige; Kazufumi Honda; Tomohiro Isobe; Hideya Kuwabara; Hirotaka Matsuzuki; Setsuo Hirohashi; Tesshi Yamada
Journal:  Mol Cell Proteomics       Date:  2006-03-21       Impact factor: 5.911

2.  Definition of a consensus binding site for p53.

Authors:  W S el-Deiry; S E Kern; J A Pietenpol; K W Kinzler; B Vogelstein
Journal:  Nat Genet       Date:  1992-04       Impact factor: 38.330

3.  Extensive post-transcriptional regulation of microRNAs and its implications for cancer.

Authors:  J Michael Thomson; Martin Newman; Joel S Parker; Elizabeth M Morin-Kensicki; Tricia Wright; Scott M Hammond
Journal:  Genes Dev       Date:  2006-08-01       Impact factor: 11.361

4.  miR-15 and miR-16 induce apoptosis by targeting BCL2.

Authors:  Amelia Cimmino; George Adrian Calin; Muller Fabbri; Marilena V Iorio; Manuela Ferracin; Masayoshi Shimizu; Sylwia E Wojcik; Rami I Aqeilan; Simona Zupo; Mariella Dono; Laura Rassenti; Hansjuerg Alder; Stefano Volinia; Chang-Gong Liu; Thomas J Kipps; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-15       Impact factor: 11.205

5.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

6.  Structure-function studies of ligand-induced epidermal growth factor receptor dimerization.

Authors:  B Neelam; A Richter; S G Chamberlin; S M Puddicombe; L Wood; M B Murray; K Nandagopal; S K Niyogi; D E Davies
Journal:  Biochemistry       Date:  1998-04-07       Impact factor: 3.162

7.  Amphiregulin: a bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF-7.

Authors:  M Shoyab; V L McDonald; J G Bradley; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

8.  The interaction of amphiregulin with nuclei and putative nuclear localization sequence binding proteins.

Authors:  B Modrell; V L McDonald; M Shoyab
Journal:  Growth Factors       Date:  1992       Impact factor: 2.511

9.  Cell surface ectodomain cleavage of human amphiregulin precursor is sensitive to a metalloprotease inhibitor. Release of a predominant N-glycosylated 43-kDa soluble form.

Authors:  C L Brown; K S Meise; G D Plowman; R J Coffey; P J Dempsey
Journal:  J Biol Chem       Date:  1998-07-03       Impact factor: 5.157

10.  The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity.

Authors:  G D Plowman; J M Green; V L McDonald; M G Neubauer; C M Disteche; G J Todaro; M Shoyab
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

View more
  13 in total

Review 1.  The DNA damage-induced cell death response: a roadmap to kill cancer cells.

Authors:  Sonja Matt; Thomas G Hofmann
Journal:  Cell Mol Life Sci       Date:  2016-01-20       Impact factor: 9.261

2.  Impairment of DYRK2 augments stem-like traits by promoting KLF4 expression in breast cancer.

Authors:  R Mimoto; Y Imawari; S Hirooka; H Takeyama; K Yoshida
Journal:  Oncogene       Date:  2016-10-10       Impact factor: 9.867

Review 3.  Engagement of DYRK2 in proper control for cell division.

Authors:  Naoe Taira Nihira; Kiyotsugu Yoshida
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 4.  Recent findings on the role of microRNAs in genetic kidney diseases.

Authors:  Hassan Askari; Ehsan Raeis-Abdollahi; Mohammad Foad Abazari; Hassan Akrami; Sina Vakili; Amir Savardashtaki; Amir Tajbakhsh; Nima Sanadgol; Asaad Azarnezhad; Leila Rahmati; Payman Raise Abdullahi; Shohreh Zare Karizi; Ali Reza Safarpour
Journal:  Mol Biol Rep       Date:  2022-06-18       Impact factor: 2.742

5.  Targeting autocrine amphiregulin robustly and reproducibly inhibits ovarian cancer in a syngeneic model: roles for wildtype p53.

Authors:  Moshit Lindzen; Soma Ghosh; Ashish Noronha; Diana Drago; Nishanth Belugali Nataraj; Orith Leitner; Silvia Carvalho; Einav Zmora; Stav Sapoznik; Keren Bahar Shany; Keren Levanon; Dan Aderka; Belinda Sánchez Ramírez; Maik Dahlhoff; Iain McNeish; Yosef Yarden
Journal:  Oncogene       Date:  2021-04-30       Impact factor: 9.867

6.  Nuclear EGFR impairs ASPP2-p53 complex-induced apoptosis by inducing SOS1 expression in hepatocellular carcinoma.

Authors:  Kai Liu; Tao Jiang; Yabo Ouyang; Ying Shi; Yunjin Zang; Ning Li; Shichun Lu; Dexi Chen
Journal:  Oncotarget       Date:  2015-06-30

7.  RGS16, a novel p53 and pRb cross-talk candidate inhibits migration and invasion of pancreatic cancer cells.

Authors:  Miranda B Carper; James Denvir; Goran Boskovic; Donald A Primerano; Pier Paolo Claudio
Journal:  Genes Cancer       Date:  2014-11

8.  miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13.

Authors:  Peijing Zhang; Li Wang; Cristian Rodriguez-Aguayo; Yuan Yuan; Bisrat G Debeb; Dahu Chen; Yutong Sun; M James You; Yongqing Liu; Douglas C Dean; Wendy A Woodward; Han Liang; Xianbin Yang; Gabriel Lopez-Berestein; Anil K Sood; Ye Hu; K Kian Ang; Junjie Chen; Li Ma
Journal:  Nat Commun       Date:  2014-12-05       Impact factor: 14.919

9.  Transcriptomic Analysis Implicates the p53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro Model.

Authors:  Cory H White; Bastiaan Moesker; Nadejda Beliakova-Bethell; Laura J Martins; Celsa A Spina; David M Margolis; Douglas D Richman; Vicente Planelles; Alberto Bosque; Christopher H Woelk
Journal:  PLoS Pathog       Date:  2016-11-29       Impact factor: 6.823

10.  Wnt3a promotes pro-angiogenic features in macrophages in vitro: Implications for stroke pathology.

Authors:  Almudena Fuster-Matanzo; Giulia Manferrari; Bianca Marchetti; Stefano Pluchino
Journal:  Exp Biol Med (Maywood)       Date:  2017-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.